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Abstract 
Background: The identification of epidemiological pattern of infection with Plasmodium falciparum and Plasmodium 
vivax in malaria‑endemic area, where multiple episodes are common, is important for intervention programmes.
Methods: A longitudinal cohort study based on weekly house‑to‑house visits was conducted between July 2008 
and June 2010 in 2040 children less than 10 years of age, living nearby the Gilgel‑Gibe hydroelectric power dam reser‑
voir in order to determine factors associated with increased P. vivax and P. falciparum incidence. Two types of multivari‑
ate frailty models were applied (using time‑to‑first malaria episode data and time‑to‑recurrent malaria episode data), 
allowing the estimation of adjusted hazard ratios (AHR) of potential risk factors (gender, age, proximity to the dam 
reservoir, and season) for species‑specific malaria incidence.
Results: Of 2040 children in 96 weeks of follow up, 864 children experienced at least one malaria episode: 685 due 
to P. falciparum in 548 children, and 385 due to P. vivax in 316 children. Plasmodium vivax and P. falciparum malaria 
incidence rates were 8.2 (95 % CI: 7.3–9.1) and 14.6 (95 % CI: 13.4–15.6) per 1000 children per month, respectively. 
According to the time‑to‑recurrent event models, children aged ≥7 years had a lower risk of presenting P. vivax 
episodes (AHR = 0.6; 95 % CI: 0.4–0.9), but a higher risk of P. falciparum episodes, when compared with children under 
≤3 years (AHR = 1.2; 95 % CI: 1.1–1.6). In addition, P. vivax (AHR = 2.7; 95 % CI: 2.2–3.5) and P. falciparum (AHR = 16.9; 
95 % CI: 14.3–20.2) episodes were respectively 2.7 and 16.9 times more frequent in the dry season than in the long 
rainy season.
Conclusions: The analysis of all malaria episodes (first and recurrent episodes) in the malaria cohort suggests differ‑
ent species‑specific patterns of malaria disease in children, with mild seasonality in the incidence of P. vivax episodes 
mostly observed in younger age groups, and with marked seasonality in the incidence of P. falciparum episodes 
mainly seen in older children.
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Background
Despite the good progress over the past decade, malaria 
remains the most important human vector-borne disease 
worldwide [1]. According to latest estimates, globally 
214 million cases and 438,000 deaths occurred in 2015, 
mainly among children under 5  years of age living in 
Africa [1]. Malaria is a major public health problem in 
Ethiopia, threatening about 70 % of the total population 
and contributing 4 % to all cases in Africa [2]. Unlike in 
most endemic African countries [3], both P. falciparum 
and P. vivax substantially contribute to malaria morbid-
ity in Ethiopia, accounting respectively for 60 and 40  % 
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of the total reported cases [4]. Species-specific malaria 
transmission is influenced by climate, topography, human 
settlement and population movement patterns; and can 
vary widely across country regions [5, 6].
Unlike P. falciparum, P. vivax can cause relapses due 
to its ability to produce latent parasite stages (hypnozo-
ites) [7, 8]. This particular biological characteristic makes 
it challenging to understand P. vivax malaria transmis-
sion, given that P. vivax recurrent episodes can be caused 
either by hypnozoite-triggered relapses, resurgence of 
erythrocytic parasites (i.e. recrudescence) due to a failure 
in the treatment, or reinfection of individuals with a new 
parasite strains following primary infections [9].
A cross-sectional community-based study conducted 
in south-western Ethiopia in 2005 reported increased P. 
falciparum and P. vivax prevalence rates by microscopy 
in households in close proximity to the Gilgel-Gibe dam 
[10]. However, the analysis of data from a 2-year (2008–
2010) cohort study, involving children living around the 
same dam, and using an approach that does not account 
for recurrent episodes, was not able to show association 
between P. falciparum clinical malaria incidence and 
household distance to the dam [11].
Researchers have often used time-to-first event models 
to analyse malaria disease data from longitudinal stud-
ies [11–14]. Those models do not take into account that 
individuals can experience multiple episodes during the 
study period and ignore the probability of occurrence of a 
new episode possibly being influenced by earlier episodes 
[15]. Time-to-recurrent models, such as the frailty model 
used in the present study, have been applied to recur-
rent event data in several studies to accommodate for the 
correlation between event times within a same subject 
[16–18]. Those models have been used to estimate the 
intervention effects using recurrent episodes in clinical 
trials [19] as well as to assess risk factors for recurrent 
health conditions [20, 21].
Using a 2-year longitudinal malaria cohort data of chil-
dren living nearby the Gilgel-Gibe dam in south-west 
Ethiopia, this study aimed to assess the effect of age, sea-
son period, and household distance to the dam on the spe-
cies-specific clinical malaria incidence (P. falciparum and 
P. vivax) and to generate evidence to strengthen the pre-
vention and control of malaria in the area. The study was 
implemented as part of several other studies, intended to 
assess the impact of the Gilgel-Gibe hydroelectric dam in 
the health and other sectors (environment, agriculture, 
economy, etc.) following its opening in 2004 [22].
Methods
Study area
The study area lies between latitudes 7°42′50″N and 
07°53′50″N and between longitudes 37°11′22″E and 
37°20′36″E at an altitude of 1734–1864 metres above sea 
level, and is located at 260 km south-west of the capital 
Addis Ababa in the Oromia region, south-western Ethio-
pia. The area is located near the Gilgel-Gibe hydroelec-
tric dam, which covers a territory of 62 km2 (Fig. 1). The 
weather is sub-humid and warm, with an annual rainfall 
between 1300 and 1800  mm, and a mean annual tem-
perature of 19 °C. Considering the rainfall pattern, three 
seasons can be identified along the year: the long rainy 
season from July to September, the dry season from 
October to March, and the moderate rainy season from 
April to June.
Sixteen villages within 10 km radius (265–9046 metres) 
from the dam reservoir shore were randomly selected 
based on similar eco-topography, access to health facili-
ties, without major impounding water nearby and homo-
geneous with respect to socio-cultural and economic 
activities [11]. The main socio-economic local activities 
are mixed farming involving the cultivation of staple 
crops (maize, teff and sorghum), and cattle and small 
stock raising. All households in selected communities 
had access to health facilities and were socio-economi-
cally similar [10]. Anopheles arabiensis is the major local 
malaria vector [11].
Study design and population
A longitudinal 2-year malaria cohort study was con-
ducted in children under 10  years old, living in the 
selected 16 villages around the Gilgel-Gibe hydroelectric 
power dam. A total of 2040 children aged <10 years were 
enrolled in July 2008, and then weekly followed up until 
June 2010. Each child was identified with a unique code, 
and selected villages and households were geo-referenced 
using a handheld global positioning system (GPS) device 
(Garmin’s GPSMAP 60CSx, Garmin International Inc., 
USA), allowing the estimation of the household distance 
to the dam.
Ethical approval
Ethical approval for the study was obtained from Jimma 
University Research and Ethics Committee. Verbal and 
written signed informed consent was obtained from the 
mother or caregiver of each child before enrollment of 
the child in the study.
Malaria follow‑up and laboratory processing
Active case detection (ACD) through weekly household 
visits allowed the identification and registration of all 
clinical malaria episodes in the study population during 
the follow-up period. During the household visits, axil-
lary temperature was taken and the caregiver was asked 
about fever history. If a child had fever (temperature 
≥37.5 °C) or reported a history of fever in the past 24 h, a 
Page 3 of 11Seyoum et al. Malar J  (2016) 15:208 
finger-prick blood sample was taken for immediate diag-
nosis by microscopy in the same site or at Omo-Nada 
district Health Center Laboratory. Microscopy diagnosis 
was conducted by trained laboratory technicians. Thick 
smears were used to confirm the presence or absence of 
parasites, whereas the thin smear was used to identify the 
Plasmodium species.
All children with microscopically confirmed malaria 
were treated according to the national treatment guide-
lines [21]. Treatment was administered by the parents and/
or guardians of the children, and consisted of 25 mg/kg 
of chloroquine (CQ) over three consecutive days for P. 
vivax, and artemether-lumefantrine (AL) for P. falcipa-
rum twice daily according to the body weight as follows: 
5–14 kg, one tablet per dose; 15–24 kg, two tablets per 
dose; 25–34  kg, three tablets per dose; and adult, four 
tablets per dose. Treatment adherence was monitored 
during household visits by asking for the medication 
packages and the remaining pills.
Absent children were followed in the next visits and 
their caregivers were asked about the occurrence of 
symptomatic episodes and/or the confirmation of malaria 
Fig. 1 Map of the study area showing the Gilgel‑Gibe hydroelectric dam reservoir, study villages and the distribution of study houses in south‑
western Ethiopia
Page 4 of 11Seyoum et al. Malar J  (2016) 15:208 
by a health facility. In addition, all the health facilities 
near the study communities were monthly visited to ver-
ify their clinical records, checking if any enrolled children 
had presented a confirmed malaria episode in the past 
month not being detected during the weekly visits.
The monthly number of episodes by species and data 
published previously on the density of A. arabiensis dur-
ing the study period were shown graphically. Mosquitoes 
were collected in all 16 communities, once a month, from 
18:00 to 6:00  h in two selected houses using light trap 
catches. Further details on the mosquito collection meth-
odology are described elsewhere [11].
Data structure for modelling first and recurrent malaria 
episodes
Malaria episode data of each child were checked care-
fully to identify a first malaria episode as well as any addi-
tional malaria episodes after the first malaria episode (i.e. 
recurrent episodes). For the time at risk, a child treated 
for a malaria episode was censured for 21 days in order to 
prevent double counting of episodes and to allow for any 
prophylactic effect of the antimalarial treatment [24].
A sub-sample data of four children in Table 1 illustrates 
the differences in the data structures required for mod-
elling first malaria episodes and recurrent malaria epi-
sodes. The time from the start of the follow-up (July 8th 
2008) to the first episode (time-to-first episode) in chil-
dren who presented malaria episodes, and the time to the 
last censorship in children who did not present malaria 
episodes was considered to model first malaria episodes. 
Therefore, this data structure excluded all additional 
information after the time of the first malaria episode. 
According to these criteria, from the sample of four chil-
dren data layout (Table 1), only data from the first row of 
each child were used to model time-to-first episodes.
Conversely, data from children with both one and more 
malaria episodes were accounted when modelling recur-
rent episodes. The time at risk for a recurrent episode in 
each child with recurrent episodes was given by the time 
between two successive malaria episodes minus 21 days 
(i.e. a discontinuous time interval data structure). For 
instance, the follow-up history of one child is described 
by the first four rows of Table 1. The first row indicates 
that the child began the follow-up at time 0 and remained 
at risk of presenting a malaria episode until day 119 
when an episode was confirmed; the second row indi-
cates that the risk of presenting another episode in the 
child re-started 21  days after a previous episode at day 
140 and ended on day 337 when the episode occurred; 
the third row indicates that the risk re-started at day 358 
and ended on day 530; and the fourth row indicates that 
the child was followed until day 696, no longer present-
ing additional malaria episodes. The second child had 
two malaria episodes at day 91 and 129 and the follow-
up ended on day 696, the third child had one malaria 
episode at day 73 and the follow-up ended on day 690 
without a malaria episode, and the fourth child had no 
episodes during the follow-up period. Additional file  1 
Table 1 Data structure showing a sample of four children malaria episode history (July 2008–June 2010) for the analysis 
of time-to-recurrent malaria episodes
ID Start date End date Gap Event Sex Age Distance Season
1 08/07/2008
0
04/11/2008
119
119 1 0 9 3.288 Dry
1 25/11/2008
140
10/06/2009
337
197 1 0 9 3.288 Long
1 01/07/2009
358
20/12/2009
530
172 1 0 9 3.288 Dry
1 10/01/2010
551
04/06/2010
696
145 0 0 9 3.288 Long
2 08/07/2008
0
07/10/2008
91
91 1 1 3 8.776 Dry
2 28/10/2008
112
14/11/2008
129
17 1 1 3 8.776 Dry
2 05/12/2008
150
04/06/2010
696
543 0 1 3 8.776 Long
3 08/07/2008
0
19/09/2008
73
73 1 1 3 7.029 Long
3 10/10/2008
94
29/05/2010
690
596 0 1 3 7.029 Moderate
4 08/07/2008
0
04/06/2010
696
696 0 0 5 5.287 Long
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shows the follow-up history of a sample of four children 
and the data structure representation for time-to-recur-
rent episode models according to a counting process (cal-
endar timescale). Figure 2a shows the children follow-up 
time line; one time line represents the total follow-up 
period history. In the calendar time layout (Fig. 2b), each 
time line represents the length of time at risk for a new 
malaria episode in the same child.
Statistical analysis
Malaria incidence rates (by species) were calculated by 
dividing the number of episodes during the study period 
by child-months at risk, and expressed as the number of 
episodes per 1000 child-months at risk. A child-month at 
risk corresponds to a child that had at least once weekly 
visit of the total 4 weeks of a specific month. Correspond-
ingly, 95 % confidence intervals (95 % CI) of the incidence 
rates were calculated assuming that the number of new 
malaria episodes was Poisson distributed.
Frailty models were applied to calculate hazard ratios 
(HRs) of species-specific incidence using separately time-
to first episode data and time-to-recurrent episode data. 
The following potential risk factors were included in the 
univariate and multivariate models: gender, age groups 
(≤3, 3–7, ≥7 years), household distance to the dam res-
ervoir (in kilometres), and season (long rainy season, dry 
season, and moderate rainy season). For covariates with 
more than two categories, a global single p value was 
calculated, using a Wald test. Models were fitted in R ver-
sion 3.2 using the package ‘frailtypack 2.5.1’ [25].
The time-to-first episode data was modelled through 
a piecewise Weibull frailty model. The piecewise inter-
val was introduced taking into account the hazard rate 
changes in malaria incidence between the different sea-
sons in the 2  years (thus in total six constants, one for 
each season and year combination). This flexible para-
metric approach has been used in a previous study aim-
ing to model malaria recurrent events, with good results 
[24]. The two parameter model is given by the formula 
h(t) = ρt∧(ρ − 1); where λ (lambda) is the scale param-
eter, and ρ (rho) the shape parameter.
The time-to-recurrent malaria episode data was mod-
elled by nested frailty models allowing to account for 
the hierarchical clustering of the data by including two 
nested random effects that act multiplicatively on the 
hazard function [25], using a calendar timescale with 
discontinuous time interval data structure. In this study, 
village was introduced as a cluster while children within 
each village were considered as a sub-cluster. The clus-
ter “village” random effect variance was estimated by Ɵ 
(theta) while the sub-cluster “individual” random effect 
variance was estimated by η (eta) from the nested frailty 
model. For model checking, martingale residual of the 
frailty model were plotted against covariates at a continu-
ous level, confirming the fit of the data when no system-
atic or clear pattern is observed [26].
Fig. 2 Monthly malaria episodes in study children in south‑western Ethiopia (July 2008–June 2010)
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Results
The 2040 children, followed-up from 2008 to June 2010, 
accounted for 46,972 child-months at risk. Male children 
(51.9  %) slightly outnumbered female children (48.1  %), 
and the median age at the time of enrolment was 5 years. 
A total of 1070 clinical malaria episodes were registered 
during the study period, including 685 episodes of P. fal-
ciparum in 548 children (421 with one episode, 119 with 
two, seven with three, and one with five episodes) and 
385 episodes of P. vivax in 316 children (263 with one 
episode, 40 with two, 10 with three, and three with four 
episodes). Plasmodium falciparum and P. vivax malaria 
incidence rates were 14.6 (95  % CI: 13.4–15.6) and 8.2 
(95 % CI: 7.3–9.1) per 1000 children per month, respec-
tively. Plasmodium falciparum episodes predominated 
over P. vivax episodes in all selected communities (Addi-
tional file 2); episodes by both species peaked during the 
dry season after an increase of the mosquito density in 
the previous months (Fig.  2). While P. vivax episodes 
were more frequent in children younger than 3 years of 
age (p  <  0.001), P. falciparum episodes occurred mostly 
in children older than 7 years (p < 0.001) (Table 2). Differ-
ences between boys and girls in the number of species-
specific malaria episodes were not statistically significant 
(p > 0.05).
Table 3 shows the follow-up-time and numbers of chil-
dren included in the time-to-first episode models and in 
the time-to-recurrent episode models. The median time 
to the first episode in 316 children (134  days) who had 
at least one P. vivax episode throughout the study period 
was slightly lower than the median time between the 
first and second episodes in 53 children (147 days), and 
between the second and third episodes in 13 children 
(172  days). On the other hand, the median time to the 
first episode in 548 children who had at least one P. fal-
ciparum episode (286 days) were higher than the median 
time between the first and second episodes in 127 chil-
dren (204 days), and between the second and third epi-
sodes in eight children (131 days).
Multivariate time-to-first episode and time-to-recur-
rent episode models showed (using global and local 
p-values) that the age of the child at enrolment and sea-
son were significantly associated with the incidence of P. 
vivax episodes even after controlling for other non-signif-
icant potential risk factors such as gender and household 
proximity to the dam (Tables  4 and 5). While adjusted 
hazard ratios (AHR), adjusted for age groups were simi-
lar in both models indicating that children aged >3 years 
old were at lower risk of presenting P. vivax episodes 
than younger children (AHR  ~  0.7; 95  % CI: ~0.5–0.9), 
AHR estimates for the effect of season categories differed 
slightly between models. P. vivax episodes occurred 1.9 
times more frequently in the dry season than in the long 
rainy season according to the time-to-first event model 
(AHR = 1.9; 95 % CI: 1.2–2.9) (Table 4), while such epi-
sodes were estimated to be 2.7 times higher in the dry 
season than in the long rainy season (AHR =  2.7; 95  % 
CI: 2.2–3.5) (Table  5), when using time-to-recurrent 
event model.
Similarly to P. vivax models, both types of multivari-
ate models for P. falciparum also found that age and 
season were significantly associated with the incidence 
of P. falciparum episodes, but with differences in AHR 
estimates (Tables 4 and 5). For the time-to-first episode 
model, children aged 3–7  years (AHR  =  1.2; 95  % CI: 
1.0–1.5) and those older than 7 years (AHR = 1.4; 95 % 
CI: 1.2–2.2) were at greater risk of having P. falciparum 
episodes than children aged ≤3  years (Table  4). Con-
versely, for the time-to-recurrent episode model, children 
older than 7 years had higher hazards of new P. falcipa-
rum episodes in comparison to children younger than or 
equal to 3 years (AHR = 1.2; 95 % CI: 1.1–1.6) (Table 5). 
Although P. falciparum episodes were most common 
in dry and moderate seasons according to both models, 
Table 2 Characteristics of  the study children by  number 
of malaria episodes
a This child had an additional episode (5th episode)
Characteristics Malaria episodes, N (%)
1 2 3 4 None  
(censored)
For P. vivax episodes
 Gender
  Male 
(N = 1059)
129 (12.2) 25 (2.3) 4 (0.4) 2 (0.2) 899 (84.9)
  Female 
(N = 981)
130 (13.3) 10 (1.0) 6 (0.6) 1 (0.1) 834 (85.0)
 Age
  ≤3 years 
(N = 974)
155 (15.9) 15 (1.6) 6 (0.6) 1 (0.1) 797 (81.8)
  3–7 years 
(N = 856)
86 (10.1) 18 (2.1) 2 (0.2) 2 (0.2) 748 (87.4)
  ≥7 years 
(N = 210)
18 (8.5) 2 (1.0) 2 (1.0) 0 (0.0) 188 (89.5)
For P. falciparum episodes
 Gender
  Male 
(N = 1059)
212 (20.0) 51 (4.8) 5 (0.5) 1 (0.1)a 790 (74.6)
  Female 
(N = 981)
209 (21.3) 68 (5.9) 2 (0.2) – 702 (71.6)
 Age
  ≤3 years 
(N = 974)
213 (21.9) 57 (5.9) 1 (0.1) 0 (0.0) 703 (72.1)
  3–7 years 
(N = 856)
170 (19.9) 45 (5.3) 2 (7.1) 0 (0.0) 639 (74.7)
  ≥7 years 
(N = 210)
38 (18.1) 17 (8.1) 4 (1.9) 1 (0.5) 150 (71.4)
Page 7 of 11Seyoum et al. Malar J  (2016) 15:208 
AHR estimates resulting from time-to-recurrent episode 
model for the dry season compared to the long rainy 
season were considerably higher (AHR = 16.9; 95 % CI: 
14.3–20.2) than the ones obtained from the time-to-first 
episode model (AHR  =  2.7; 95  % CI: 2.2–3.5). Gender 
and distance to the dam were not significantly associated 
with P. falciparum incidence in both models. Regard-
ing model parameter estimates, ρ values lower than one, 
indicated that for both species incidence rates decreased 
with time, but incidence rates for P. vivax (ρ ~ 0.7) dur-
ing the study period decreased faster than those for P. 
falciparum (ρ  ~  0.8). The malaria risk variation among 
villages for P. falciparum (ɵ ~ 0.5) was higher than for P. 
vivax (ɵ ~ 0.3). Moreover, malaria risk variation among 
children (η) were higher for P. vivax than for P. falcipa-
rum. Additional file 3 shows the fit of the data by plotting 
martingale residual by the covariate at a continuous level. 
The lowess estimates did not show a clear pattern, sug-
gesting a good fit.
Discussion
This study reports species-specific clinical malaria epi-
sode patterns in a 2-year longitudinal cohort study 
of 2040 children under 10  years old living nearby the 
Gilgel-Gibe hydropower dam, in south-western Ethio-
pia. Multiple P. falciparum and P. vivax malaria episodes 
occurred in respectively 127 and 53 children along the 
study period. Plasmodium vivax clinical episodes were 
more obvious in younger age groups and occurred 
mostly in the dry season, while P. falciparum episodes 
predominated in older children and occurred in the dry 
and moderate season but with a substantial peak in the 
first months of the dry season. Both P. vivax and P. fal-
ciparum incidence rates decreased with time and were 
not associated with the household proximity to the dam 
reservoir.
This is the first study analysing recurrent malaria epi-
sodes with two statistical approaches, i.e. time-to-first 
event models and time-to-recurrent event models with 
discontinuous risk intervals. Although no major differ-
ences in parameter estimates for evaluating risk factors 
were found between both models using the data at hand, 
it is not the rule for all health conditions with recurrent 
episodes and possibly mainly explained by the low occur-
rence of recurrent malaria episodes in the study. Indeed, 
a re-analysis of data from a pneumococcal conjugate 
vaccine trial and the simulation of scenarios found that 
the difference between effect estimates of the vaccine 
obtained from time-to-first event models and time-to-
recurrent event models was substantial especially when 
a high incidence of recurrent episodes was noted [27]. 
Moreover, a number of studies dealing with recurrent 
Table 3 Number of children by the number of episodes for both species, along with time included in time-to-first event 
and time-to-recurrent event models
a This child had an additional episode (5th episode)
Follow‑up
Until 1st episode Between 1st  
and 2nd episodes
Between 2nd  
and 3rd episodes
Between 3rd 
and 4th episodes
For P. vivax episodes
 Number of followed‑up children
  Total (N) 2040 316 53 13
  With episodes 316 53 13 3
  Censored 1724 263 40 10
 Follow‑up time
  Mean (days) 221 208 196 139
  Median (days) 134 147 172 99
  [Min.–max.] [7–696] [9–621] [49–402] [66–180]
For P. falciparum episodes
 Number of followed‑up children
  Total (N) 2040 548 127 8
  With episodes 548 127 8 1a
  Censored 1492 421 119 7
 Follow‑up time
  Mean (days) 283 233 133 111
  Median (days) 286 204 131 105
  [Min.–max.] [7–696] [9–639] [66–339] [63–189]
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health conditions have observed different results when 
applying both models separately [15, 24, 26, 28].
The shape model parameter value below one confirmed 
that malaria incidence rates for both species decreased 
with time during the study period. A similar decreasing 
malaria incidence trend has been reported in southwest 
Ethiopia [29] and may be explained by positive effects of 
control interventions in the area. Indeed, the government 
re-started indoor residual spraying with deltamethrin 
in 2009 and replaced old long-lasting insecticidal nets 
(LLINs) in 2010 [30].
Although previous studies in Ethiopia and other Afri-
can countries have reported dams influencing malaria 
transmission by increasing vector abundance due to 
breeding sites associated with dam´s floods on the shore-
lines [6, 31–33], the present study did not identify an 
association between the proximity to the Gilgel-Gibe 
dam reservoir and the species-specific clinical malaria 
incidence. The design and the automatic operation of 
this dam may prevent the appearance of shoreline pud-
dles and consequently the formation of breeding sites 
near the dam [32]. On the other hand, agriculture field 
puddles, wet lands, man-made pools, and rain pools 
located extensively in all the study area would become 
the most important sources of mosquitoes, and these 
sources may significantly enlarge after the long rainy sea-
son. In addition, since the main economic activities in 
the communities are related to cattle, animal hoof-prints 
filled with water would emerge after rains, thus facilitat-
ing the development of mosquitoes [34].
The differences in clinical malaria incidence between 
species with respect to age may be related to a differ-
ent species-specific acquisition rate of immunity in 
the Ethiopian children, which may be related to differ-
ent exposure levels for both species in the early years 
of live. Those differences are in line with previous find-
ings from longitudinal studies conducted in co-endemic 
malaria areas of Papua New Guinea [8, 14, 35]. Malarial 
immunity in New Guinean children is acquired much 
more rapidly with P. vivax than with P. falciparum. After 
5 years of continuous exposure, children can acquire an 
almost complete clinical immunity to P. vivax, which 
is characterized by their control of blood-stage para-
site densities rather than the acquisition of a significant 
immunity against infection [14, 35]. This differential 
pattern between species was also reported in low trans-
mission setting. In longitudinal studies conducted in 
Thailand [36, 37], and in Vanuatu [38] the incidence of P. 
vivax malaria also decreased significantly faster with age 
than that the incidence of P. falciparum, while a cohort 
study in the Brazilian Amazon indicated that P. vivax 
malaria started to decrease after 5–6 years of residence 
in the endemic area compared to 8–9 years for P. falci-
parum [39].
Table 4 Univariate and multivariate adjusted risk factors analysis for time-to-first P. vivax episode and P. falciparum epi-
sode
HR hazard ratio; AHR adjusted hazard ratio; G p-value global p-value
* P < 0.05
P. vivax P. falciparum
Univariate HR  
(95 % CI)
Multivariate AHR  
(95 % CI)
G p‑value Univariate HR  
(95 % CI)
Multivariate AHR  
(95 % CI)
G p‑value
Gender
 Female 1 1 1 1
 Male 1.0 (0.8,1.2) 0.9 (0.8,1.2) 0.9 (0.8,1.1) 0.9 (0.8,1.1)
Age (years)
 ≤3 1 1 0.01* 1 1 <0.01*
 3–7 0.8* (0.6,1.0) 0.7* (0.6,0.9) 1.2 (1.0,1.5) 1.2* (1.0,1.5)
 ≥7 0.6 (0.4,1.0) 0.6* (0.4,0.9) 1.4* (1.1,1.9) 1.4* (1.2,2.2)
Proximity to the dam
 ≤1.17 km 1 1 0.12 1 1 0.53
 1.17–1.79 0.8 (0.6,1.2) 0.9 (0.6,1.2) 0.9 (0.7,1.2) 1.0 (0.7,1.2)
 1.79–2.97 0.9 (0.6,1.3) 0.8 (0.5,1.3) 0.9 (0.7,1.2) 1.0 (0.7,1.3)
 >2.97 0.8 (0.5,1.5) 0.8 (0.5,1.4) 1.1 (0.8,1.7) 1.1 (0.8,1.5)
Season
 Long rainy 1 1 <0.01* 1 1 <0.01*
 Dry 1.7* (1.1,2.3) 1.9* (1.2,2.9) 1.7* (1.2,2.8) 3.2 (2.2,5.2)
 Moderate rainy 0.8 (0.7,1.1) 0.8 (0.6,1.2) 1.2* (1.0,2.0) 2.3* (1.4,3.1)
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Although a weekly identification of symptomatic chil-
dren and the consequent diagnosis and treatment of 
malaria infections during the study are likely to have con-
tributed to the decrease of malaria transmission in the 
area and consequently possibly explain the decrease of 
the malaria incidence rate in time, it is worth to notice 
that the decrease may also be associated with the acquisi-
tion of immunity in the study children. Further longitudi-
nal studies incorporating the detection and follow-up of 
both symptomatic and asymptomatic infections in young 
children are necessary to understand the role of immu-
nity (i.e. immunity to infection and/or clinical immunity) 
in the malaria transmission in the co-endemic Ethiopia 
[8, 14, 35].
Many studies have reported high mosquito densities 
and an increased malaria risk following the rainy sea-
son [5, 40]. After rainy periods, intermittent streams 
could create pockets or pools of water which can serve 
as potential breeding sites for mosquitoes, contributing 
to an increase in mosquito density and vector-human 
contacts; therefore contributing to a greater number 
of malaria episodes during the dry season. Although 
malaria is transmitted by both species in the study, it 
occurred seasonally and mainly after increased rainfall, 
P. vivax clinical episodes being less sensitive to seasonal 
and environmental changes than P. falciparum, an 
important proportion of the former possibly being hyp-
nozoite-triggered relapses [7–9]. This hypothesis is fur-
ther supported by the fact that children with confirmed P. 
vivax episodes only received CQ, following the national 
guidelines for areas where the glucose-6-phosphate dehy-
drogenase deficiency (G6PD deficiency) is not known 
and where tests to detect that condition are not avail-
able [23]. A previous study that used a life-table method 
showed that in Ethiopia the cumulative risk of recur-
rent episodes at day 157 was significantly higher in the 
CQ group (61.8  %), compared with the CQ +  PQ (pri-
maquine) group (26.3 %) [41].
Conclusion
The analysis of all malaria episodes (first and recurrent epi-
sodes) found different species-specific patterns of malaria 
disease in the enrolled children, with mild seasonality in 
the incidence of P. vivax episodes, mostly seen in younger 
age groups, and with marked seasonality in the incidence 
of P. falciparum episodes mainly observed in older chil-
dren. The decision-making and planning of malaria control 
interventions will have to consider the seasonal patterns of 
Table 5 Univariate and multivariate adjusted risk factors analysis for time-to-recurrent P. vivax episodes and P. falcipa-
rum episodes
HR hazard ratio; AHR adjusted hazard ratio; SE standard error, G p-value global p-value
* P < 0.05
P. vivax P. falciparum
Univariate HR  
(95 % CI)
Multivariate AHR  
(95 % CI)
G P‑value Univariate HR  
(95 % CI)
Multivariate AHR  
(95 % CI)
G P‑value
Gender
 Female 1 1 1 1
 Male 1.0 (0.8,1.2) 1.0 (0.8,1.2) 0.9 (0.8,1.1) 0.9 (0.7,1.0)
Age (years)
 ≤3 1 1 <0.01* 1 1 0.02*
 3–7 0.8 (0.6,1.0) 0.7* (0.6,0.9) 1.2 (0.9,1.4) 0.9 (0.8,1.1)
 ≥7 0.6* (0.4,0.9) 0.6* (0.4,0.9) 1.7* (1.3,2.2) 1.2* (1.1,1.6)
Proximity to the dam
 ≤1.17 km 1 1 0.25 1 1 0.91
1.17–1.79 0.8 (0.7,1.1) 0.8 (0.6,1.1) 0.9 (0.8,1.1) 0.9 (0.7,1.2)
1.79–2.97 0.9 (0.7,1.1) 0.9 (0.7,1.2) 1.0 (0.8,1.1) 1.0 (0.8,1.3)
 >2.97 1.0 (0.8,1.3) 0.9 (0.7,1.2) 1.1 (0.9,1.3) 1.1 (0.9,1.3)
Season
 Long rainy 1 1 <0.01* 1 1 <0.01*
 Dry 2.9* (2.2,3.9) 2.7* (2.2,3.5) 14.6* (12.0,17.7) 16.9 (14.3,20.2)
 Moderate rainy 0.9 (0.6,1.2) 1.0 (0.8,1.3) 1.1 (0.8,1.4) 1.4* (1.1,1.8)
Model parameters
 ρ 0.75 0.86
 Ɵ (SE) 0.36 (0.13) 0.58 (0.27)
 η (SE) 0.62 (0.26) 0.46 (0.19)
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malaria transmission in order to reduce malaria incidence, 
as well as a species-specific policy.
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